Osiris Therapeutics (NASDAQ:OSIR)

Osiris Therapeutics (NASDAQ:OSIR)

Share Price
0 (0 %)
Market Cap
$0.00 m
Proactive Investors - Run By Investors For Investors

Osiris Therapeutics

Osiris Therapeutics, Inc. (Osiris) is a stem cell therapeutic company. It focuses on developing and marketing products to treat serious medical conditions in the inflammatory, autoimmune, orthopedic and cardiovascular areas. The Company’s biologic drug candidate, Prochymal, is being evaluated in Phase III clinical trials for four indications, including acute and steroid refractory graft...

Sector: Health Care, Equipment & Services
Website: www.osiris.com
col 3
col 4
col 5
col 6

Osiris Therapeutics Timeline

Market Reports Including OSIR


© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use